Global Acute Myeloid Leukemia (AML) Treatment Market Trends Analysis Report 2023-2028 - Personalized Medicine and Patient Advocacy Drive Opportunities

News provided by

Oct 20, 2023, 05:45 ET

DUBLIN, Oct. 20, 2023 /PRNewswire/ -- The "Global Acute Myeloid Leukemia (AML) Treatment Market: Forecast and Trends" report has been added to ResearchAndMarkets.com's offering.

The global AML treatment market was valued at nearly $3.5 billion in 2022. The market is expected to grow at a compound annual growth rate (CAGR) of 10.0%, expected to reach $6.1 billion by 2028.

This study's primary objective is to conduct a comprehensive analysis of the AML treatment market, offering insights into its dynamics, prevailing trends, and the overall market landscape.

The market's growth is primarily driven by the global increase in the elderly population and a higher incidence of AML cases. Technological advancements play a pivotal role in fostering innovation and the adoption of new treatment methods.

The year 2020 witnessed a significant impact on AML treatment due to the COVID-19 pandemic, resulting in the temporary closure of cancer hospitals and disruptions in chemotherapy procedures. However, as the world transitioned towards normalcy in the latter half of 2021, the resumption of elective procedures has contributed to increased sales of AML treatments.

In 2022, the targeted therapy segment emerged as the dominant player in the market, commanding a substantial market share of approximately 92.6%, followed by anthracycline drugs and other chemotherapies, each holding a share of 3.7%.

Reasons for Doing This Study:

The incidence of Acute Myeloid Leukemia (AML) is on the rise, particularly among the elderly population, in tandem with the overall growth of the elderly demographic. Factors contributing to this trend include lower mortality rates and declining fertility rates. Technological advancements in the field of blood cancer have played a pivotal role in propelling the AML treatment market forward.

However, it is important to note that the COVID-19 pandemic exerted a significant impact on AML treatment rates. The implementation of lockdown measures and restrictions on patient access to chemotherapy treatments led to a noticeable decline in treatment rates during this challenging period.

The objective of this report is to provide a comprehensive assessment of the global AML market size and its associated treatments. By analyzing treatment type, route of administration, end use, distribution channel, and regional factors, both current and historical market revenues can be estimated effectively.

Report Includes

42 data tables and 57 additional tables
An overview of the global market for acute myeloid leukemia (AML) treatment
Analyses of global market trends, with data from 2020 to 2022, estimates for 2023 and projections of compound annual growth rates (CAGRs) through 2028
Highlights of the market potential and characterization of AML market based on treatment type, route of administration type, end-users, distribution channel, region
Coverage of various risk factors associated with AML, such as exposure to radiation or chemicals, genetic disorders, and weakened immune system
Description of major treatment options for AML such as, chemotherapy, targeted therapy, and stem cell transplantation
Information on recent mergers, acquisitions, collaborations, agreements, partnerships, product launches, and expansions in the market and a relevant patent analysis
Detailed company profiles of major players in the market of the industry, including AbbVie, Daiichi Sankyo, GlaxoSmithKline PLC, Pfizer Inc. and Servier

Company Profiles

Abbvie
Amgen Inc.
Astellas Pharma Inc.
Bayer AG
Biogen
Bristol Myers Squibb
Daiichi Sankyo Co. Ltd.
Gilead Sciences Inc.
GlaxoSmithKline plc
Merck & Co. Inc.
Novartis
Pfizer Inc.
Sanofi
Servier Laboratories
Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Market Outlook
This Report Highlights

Chapter 3 Market Overview and Definitions

Overview
Acute Myeloid Leukemia
The Global Regulatory Structure for Aml
Pricing and Reimbursement for Aml
Therapies/Drugs to Treat Aml
Flt3 Inhibitors
Idh Inhibitors
Apoptosis Stimulants
DNA Methylation Inhibitors
DNA Intercalators
Angiogenesis Inhibitors
DNA Synthesis Inhibitors

Chapter 4 Market Dynamics

Market Drivers
Growing Elderly Population
Increasing Incidence and Prevalence
Advancements in Molecular Diagnostics
Minimal Residual Disease (Mrd) Monitoring
Gene Expression Profiling
Fusion Gene Detection
Liquid Biopsies
R&D
Regulatory Environment
Personalized Medicine
Collaborative Efforts
Patient Advocacy and Awareness
Market Opportunity
Strategic Initiative
Market Restraints
High Costs
Limited Treatment Options
Treatment-Related Toxicity and Adverse Effects
Regulatory and Reimbursement Challenges

Chapter 5 Impact of Covid-19

Introduction
Covid-19 Impact on Aml Treatments
Chapter 6 Market Breakdown by Region
Market Overview and Discussion
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Market Breakdown by Treatment Type

Market Overview and Discussion
Targeted Therapy
Anthracycline Drugs
Other Chemotherapies
Targeted Therapy
Anthracycline Drugs
Other Chemotherapies

Chapter 8 Market Breakdown by Route of Administration

Market Overview and Discussion
Intravenous (Iv) Administration
Oral Administration
Intravenous (Iv) Administration

Chapter 9 Market Breakdown by Product

Flt3 Inhibitors
Apoptosis Stimulants
Angiogenesis Inhibitors
DNA Methylation Inhibitors
DNA Synthesis Inhibitors
DNA Intercalators

Chapter 10 Esg Development

Introduction
Environment
Governance

Chapter 11 Emerging Trends and Technologies

Introduction

Chapter 12 Competitive Landscape

Overview
Industry Scenario
Company Shares

Chapter 13 Patent Analysis

Patent Analysis by Manufacturer

Chapter 14 Pipeline Analysis

Clinical Trail Scenario

Chapter 15 M&A and Venture Funding Outlook

For more information about this report visit https://www.researchandmarkets.com/r/um4d70

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets